(Total Views: 685)
Posted On: 12/11/2019 3:42:59 PM
Post# of 145254
![Avatar](https://investorshangout.com/images/ProfileImages/573000060_60093_FD245EF6-37BD-4C88-9356-29519D0376AD.jpeg)
Re: craigakess #12489
IMO, if leronlimab is proven to treat a wide variety of metastatic cancers, then the price for the drug can and will be reasonably priced because there will be a broad demand for it. This is in contrast to a drug developed and approved for a disease with only a few hundred or few thousand patients, which may be priced in the 6-7 figure range.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)